PALATIN TECHNOLOGIES, INC. Proceeds from Sale and Maturity of Marketable Securities
PALATIN TECHNOLOGIES, INC. (PTN) reported Proceeds from Sale and Maturity of Marketable Securities of $0 for the 12-month period ending 2025-06-30, per its 10-K filed 2025-09-23.
Financial Statements › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities · last filed 2025-09-23
- PALATIN TECHNOLOGIES, INC. proceeds from sale and maturity of marketable securities for the quarter ending 2025-06-30 was $0.00.
- PALATIN TECHNOLOGIES, INC. proceeds from sale and maturity of marketable securities for the quarter ending 2025-03-31 was $0.00.
- PALATIN TECHNOLOGIES, INC. proceeds from sale and maturity of marketable securities for the quarter ending 2024-12-31 was $0.00.
- PALATIN TECHNOLOGIES, INC. proceeds from sale and maturity of marketable securities for the quarter ending 2024-09-30 was $0.00, a 100.00% decline year-over-year.
- PALATIN TECHNOLOGIES, INC. proceeds from sale and maturity of marketable securities for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- PALATIN TECHNOLOGIES, INC. proceeds from sale and maturity of marketable securities for fiscal 2024 was $2.99M.
- PALATIN TECHNOLOGIES, INC. proceeds from sale and maturity of marketable securities for fiscal 2023 was $0.00.
| Period end | Proceeds from Sale and Maturity of Marketable Securities 3 month | Proceeds from Sale and Maturity of Marketable Securities 6 month | Proceeds from Sale and Maturity of Marketable Securities 9 month | Proceeds from Sale and Maturity of Marketable Securities 12 month |
|---|---|---|---|---|
| 2025-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-23 | $0.00 derived: sum of 2 quarters · filed 2025-09-23 | $0.00 derived: sum of 3 quarters · filed 2025-09-23 | $0.00 10-K · filed 2025-09-23 |
| 2025-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-14 | $0.00 derived: sum of 2 quarters · filed 2025-05-14 | $0.00 10-Q · filed 2025-05-14 | $0.00 derived: sum of 4 quarters · filed 2025-09-23 |
| 2024-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-02-13 | $0.00 10-Q · filed 2025-02-13 | $0.00 derived: sum of 3 quarters · filed 2025-09-23 | $0.00 derived: sum of 4 quarters · filed 2025-09-23 |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-14 | $0.00 derived: sum of 2 quarters · filed 2025-09-23 | $0.00 derived: sum of 3 quarters · filed 2025-09-23 | $0.00 derived: sum of 4 quarters · filed 2025-09-23 |
| 2024-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-23 | $0.00 derived: sum of 2 quarters · filed 2025-09-23 | $0.00 derived: sum of 3 quarters · filed 2025-09-23 | $2.99M 10-K · filed 2025-09-23 |
| 2024-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-14 | $0.00 derived: sum of 2 quarters · filed 2025-05-14 | $2.99M 10-Q · filed 2025-05-14 | $2.99M derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-02-13 | $2.99M 10-Q · filed 2025-02-13 | $2.99M derived: sum of 3 quarters · filed 2025-02-13 | $2.99M derived: sum of 4 quarters · filed 2025-02-13 |
| 2023-09-30 | $2.99M 10-Q · filed 2024-11-14 | $2.99M derived: sum of 2 quarters · filed 2024-11-14 | $2.99M derived: sum of 3 quarters · filed 2024-11-14 | $2.99M derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-30 | $0.00 derived: sum of 2 quarters · filed 2024-09-30 | $0.00 derived: sum of 3 quarters · filed 2024-09-30 | $0.00 10-K · filed 2024-09-30 |
| 2023-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-15 | $0.00 derived: sum of 2 quarters · filed 2024-05-15 | $0.00 10-Q · filed 2024-05-15 | |
| 2022-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-02-14 | $0.00 10-Q · filed 2024-02-14 | ||
| 2022-09-30 | $0.00 10-Q · filed 2023-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |